ARCHIVES

Rabson Recommended For NCI Acting Director, Will be Top Prospect For Permanent Appointment

This article is from The Cancer Letter archive.

Vol. 14 No. 35 | August 26, 1988

Download PDF Visit The Full Archive

Related Articles

DCT Board Approves Continuing Neutron Trials Pas 1989 Expiration, With New Funding Plan

June 10, 1988

FDA Approves Bexxar For Non-Hodgkin’s Lymphoma

June 27, 2003

Group Chairs Seek Role Running NCTN

September 12, 2014

Task Force Recommendations Submitted For Control/Centers New Division

August 3, 1979

In Brief: CRCC, One Of The 21 Comprehensive Centers, To Close Up; Steckel New AACI President

January 30, 1981

Annual Report Finds Decreases In Overall Cancer Rates

December 11, 2009